Meeting
2013 ASCO Annual Meeting
Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC).
Authors
Dinny Graham
Westmead Institute for Cancer Research, Sydney Medical School – Westmead, Sydney, Australia
Dinny Graham , Jacques Bosq , Jean-Michel Caillaud , Matthew A. Powell , Eric Leblanc , Keiichi Fujiwara , Thomas J. Herzog , Bradley J. Monk , Christine Clarke , Alexander A. Zukiwski , Erard M. Gilles , Robert L. Coleman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 5602)
DOI
10.1200/jco.2013.31.15_suppl.5602
Abstract #
5602
Poster Bd #
53H
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC).
First Author: Jacques Bosq
Poster
2015 ASCO Annual Meeting
Does metformin use affect transporter, hormone receptor and mTOR pathway target expression in endometrial cancers of women with Type II diabetes mellitus?
First Author: Dario R. Roque
Poster
2013 ASCO Annual Meeting
Independent characterization by duel staining of progesterone receptor (PR) and estrogen receptor (ER) in breast cancer (BC).
First Author: Alexander A. Zukiwski
Poster
2023 ASCO Annual Meeting
Association of the Duffy-null allele and endometrial cancer characteristics: An effort to explore racial disparity in Black women with endometrial cancer.
First Author: Emily M. Webster